Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-10-23
pubmed:abstractText
Parkinson disease (PD) is the second-most common age-related neurodegenerative disease and is characterized by the selective destruction of dopaminergic neurons. Increasing evidence indicates that oxidative stress plays a crucial role in the pathogenesis of idiopathic PD. Anti-oxidant agents including catalase, manganese porphyrin and pyruvate confer cytoprotection to different cell cultures when challenged with 6-hydroxydopamine (6-OHDA). Herein we used rat cerebellar granular cell cultures to ascertain the plausible cellular pathways involved in pyruvate-induced cytoprotection against 0.1 mM 6-OHDA. Pyruvate provided cytoprotection in a concentration-dependent manner (2-10 mM). Consistent with its well-established anti-oxidant capacity, pyruvate (10 mM) prevented 6-OHDA-induced lipid peroxidation by blocking the rise in intracellular peroxides and maintaining the intracellular reduced glutathione (GSH) levels. Further experiments revealed that pyruvate increased Akt, but not extracellular signal-regulated kinase phosphorylation. Moreover, phosphatidylinositol 3-kinase (PI3K) inhibitors attenuated pyruvate-induced cytoprotection indicating that PI3K-mediated Akt activation is necessary for pyruvate to induce cytoprotection. On the other hand, pyruvate also up-regulated glutathione peroxidase mRNA levels, but not those of the anti-oxidant enzymes superoxide dismutase-1 and -2, catalase or the anti-apoptotic oncogenes Bcl-2 or Bcl-xL. In summary, our results strongly suggest that pyruvate, besides the anti-oxidant properties related to its structure, exerts cytoprotective actions by activating different anti-apoptotic routes that include gene regulation and Akt pathway activation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0969-9961
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
296-307
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16978869-Animals, pubmed-meshheading:16978869-Animals, Newborn, pubmed-meshheading:16978869-Antioxidants, pubmed-meshheading:16978869-Apoptosis, pubmed-meshheading:16978869-Cells, Cultured, pubmed-meshheading:16978869-Cerebellar Cortex, pubmed-meshheading:16978869-Cytoprotection, pubmed-meshheading:16978869-Dose-Response Relationship, Drug, pubmed-meshheading:16978869-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:16978869-Glutathione Peroxidase, pubmed-meshheading:16978869-Lipid Peroxidation, pubmed-meshheading:16978869-Nerve Degeneration, pubmed-meshheading:16978869-Neurons, pubmed-meshheading:16978869-Neuroprotective Agents, pubmed-meshheading:16978869-Neurotoxins, pubmed-meshheading:16978869-Oxidative Stress, pubmed-meshheading:16978869-Oxidopamine, pubmed-meshheading:16978869-Phosphatidylinositol 3-Kinases, pubmed-meshheading:16978869-Proto-Oncogene Proteins c-akt, pubmed-meshheading:16978869-Pyruvic Acid, pubmed-meshheading:16978869-RNA, Messenger, pubmed-meshheading:16978869-Rats, pubmed-meshheading:16978869-Signal Transduction, pubmed-meshheading:16978869-Up-Regulation
pubmed:year
2006
pubmed:articleTitle
Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.
pubmed:affiliation
Departamento de Ciencias Médicas, Facultad de Medicina, Universidad Castilla-La Mancha, and Servicio de Farmacia, Complejo Hospitalario Universitario de Albacete, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't